Exhibit 15.1


                    REVIEW REPORT OF INDEPENDENT ACCOUNTANTS





The Board of Directors of
ICN Pharmaceuticals, Inc.

We have reviewed the accompanying  consolidated  condensed  balance sheet of ICN
Pharmaceuticals,  Inc.  and  subsidiaries  as of June 30,  1999 and the  related
consolidated condensed statements of income, comprehensive income and cash flows
for each of the three month and six month  periods ended June 30, 1999 and 1998.
These consolidated  condensed financial statements are the responsibility of the
Company's management.

We conducted our review in accordance with standards established by the American
Institute  of  Certified  Public  Accountants.  A review  of  interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with  generally  accepted  auditing  standards,  the  objective  of which is the
expression of an opinion  regarding the financial  statements  taken as a whole.
Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the accompanying  consolidated condensed interim financial statements
for them to be in conformity with generally accepted accounting principles.

We have  previously  audited in  accordance  with  generally  accepted  auditing
standards,  the  consolidated  balance  sheet as of December 31,  1998,  and the
related consolidated statements of income,  stockholders' equity, and cash flows
for the year then ended (not presented herein), and in our report dated March 4,
1999,  which included an emphasis of matter  paragraph  related to the Company's
change in method of accounting  for ICN  Yugoslavia,  a previously  consolidated
subsidiary,  as more  fully  described  in  Notes  2 and 14 to the  consolidated
statements,  we expressed an unqualified opinion on those consolidated financial
statements.  In our  opinion,  the  information  set  forth in the  consolidated
condensed  balance  sheet as of  December  31,  1998,  is  fairly  stated in all
material  respects in relation to the  consolidated  balance sheet from which it
has been derived.

/S/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP
Newport Beach, California
August 11, 1999